Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $122 - $147
2 Added 0.03%
7,373 $538,000
Q4 2021

Feb 10, 2022

SELL
$53.63 - $62.52 $72,025 - $83,964
-1,343 Reduced 15.41%
7,371 $460,000
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $118 - $138
2 Added 0.02%
8,714 $519,000
Q2 2021

Aug 06, 2021

SELL
$61.91 - $67.42 $11,267 - $12,270
-182 Reduced 2.05%
8,712 $582,000
Q1 2021

May 10, 2021

SELL
$59.34 - $66.74 $13,944 - $15,683
-235 Reduced 2.57%
8,894 $561,000
Q4 2020

Feb 05, 2021

BUY
$57.74 - $65.43 $173 - $196
3 Added 0.03%
9,129 $566,000
Q3 2020

Oct 29, 2020

SELL
$57.43 - $63.64 $13,208 - $14,637
-230 Reduced 2.46%
9,126 $550,000
Q2 2020

Aug 11, 2020

BUY
$54.82 - $64.09 $109,749 - $128,308
2,002 Added 27.22%
9,356 $550,000
Q1 2020

May 12, 2020

SELL
$46.4 - $67.43 $129,827 - $188,669
-2,798 Reduced 27.56%
7,354 $410,000
Q4 2019

Feb 11, 2020

BUY
$49.21 - $64.19 $1,722 - $2,246
35 Added 0.35%
10,152 $652,000
Q3 2019

Nov 05, 2019

BUY
$42.77 - $50.71 $51,409 - $60,953
1,202 Added 13.48%
10,117 $513,000
Q2 2019

Aug 05, 2019

SELL
$44.62 - $49.34 $53,410 - $59,059
-1,197 Reduced 11.84%
8,915 $404,000
Q1 2019

May 09, 2019

SELL
$45.12 - $53.8 $36,005 - $42,932
-798 Reduced 7.31%
10,112 $482,000
Q4 2018

Feb 01, 2019

BUY
$48.76 - $63.23 $27,841 - $36,104
571 Added 5.52%
10,910 $572,000
Q3 2018

Oct 25, 2018

BUY
$55.19 - $62.25 $110 - $124
2 Added 0.02%
10,339 $642,000
Q2 2018

Jul 31, 2018

BUY
$50.53 - $62.98 $101 - $125
2 Added 0.02%
10,337 $572,000
Q1 2018

May 10, 2018

BUY
$59.92 - $68.98 $70,645 - $81,327
1,179 Added 12.88%
10,335 $654,000
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $395,184 - $430,852
6,593 Added 257.24%
9,156 $561,000
Q4 2017

Feb 09, 2018

BUY
$59.94 - $65.35 $153,626 - $167,492
2,563
2,563 $157,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Taylor Hoffman Wealth Management Portfolio

Follow Taylor Hoffman Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor Hoffman Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Taylor Hoffman Wealth Management with notifications on news.